19-5914580-A-G
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_004058.5(CAPS):āc.101A>Gā(p.Asp34Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000323 in 1,608,428 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00014 ( 0 hom., cov: 33)
Exomes š: 0.000021 ( 0 hom. )
Consequence
CAPS
NM_004058.5 missense
NM_004058.5 missense
Scores
7
6
3
Clinical Significance
Conservation
PhyloP100: 5.88
Genes affected
CAPS (HGNC:1487): (calcyphosine) This gene encodes a calcium-binding protein, which may play a role in the regulation of ion transport. A similar protein was first described as a potentially important regulatory protein in the dog thyroid and was termed as R2D5 antigen in rabbit. Alternative splicing of this gene generates two transcript variants. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.964
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPS | NM_004058.5 | c.101A>G | p.Asp34Gly | missense_variant | 3/5 | ENST00000588776.8 | NP_004049.3 | |
CAPS | NM_080590.4 | c.101A>G | p.Asp34Gly | missense_variant | 3/5 | NP_542157.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPS | ENST00000588776.8 | c.101A>G | p.Asp34Gly | missense_variant | 3/5 | 1 | NM_004058.5 | ENSP00000465883.2 | ||
ENSG00000267314 | ENST00000588891.1 | n.*196A>G | non_coding_transcript_exon_variant | 4/4 | 4 | ENSP00000468419.1 | ||||
ENSG00000267314 | ENST00000588891.1 | n.*196A>G | 3_prime_UTR_variant | 4/4 | 4 | ENSP00000468419.1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152106Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
21
AN:
152106
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 249092Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134752
GnomAD3 exomes
AF:
AC:
9
AN:
249092
Hom.:
AF XY:
AC XY:
3
AN XY:
134752
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000213 AC: 31AN: 1456204Hom.: 0 Cov.: 33 AF XY: 0.0000124 AC XY: 9AN XY: 723396
GnomAD4 exome
AF:
AC:
31
AN:
1456204
Hom.:
Cov.:
33
AF XY:
AC XY:
9
AN XY:
723396
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000138 AC: 21AN: 152224Hom.: 0 Cov.: 33 AF XY: 0.000202 AC XY: 15AN XY: 74436
GnomAD4 genome
AF:
AC:
21
AN:
152224
Hom.:
Cov.:
33
AF XY:
AC XY:
15
AN XY:
74436
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2024 | The c.101A>G (p.D34G) alteration is located in exon 3 (coding exon 2) of the CAPS gene. This alteration results from a A to G substitution at nucleotide position 101, causing the aspartic acid (D) at amino acid position 34 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
.;.;D
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
PrimateAI
Benign
T
REVEL
Pathogenic
Sift4G
Uncertain
D;D;D
Vest4
MVP
ClinPred
D
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 0
Find out detailed SpliceAI scores and Pangolin per-transcript scores at